Amneal Pharmaceuticals, Inc. - 8-K Filing
Amneal Pharmaceuticals held its 2026 Annual Meeting of Stockholders on May 6, 2026, where all proposals were approved. Director nominees including Deb Autor, J. Kevin Buchi, Jeff George, and others were elected with vote counts ranging from 237,733,309 to 270,643,127 votes in favor. Proposal 2, approving executive compensation, received 269,089,785 votes in favor, and Proposal 3, ratifying Ernst & Young LLP as the independent auditor, received 293,211,820 votes in favor.
Tickers: $AMRX